Blood pressure management in stroke

BP Goals in Stroke - The Core Principles

• Permissive Hypertension: In most ischemic strokes, elevated BP is allowed to maintain perfusion to the salvageable ischemic penumbra.
• Hemorrhage Control: In hemorrhagic strokes, lowering BP is prioritized to limit hematoma expansion and re-bleeding.

⭐ High-Yield: In ischemic stroke without thrombolysis, aggressively lowering BP can harm the patient by reducing perfusion to the penumbra, worsening the neurological outcome.

Ischemic Stroke - Permissive Hypertension

• Rationale: In acute ischemia, cerebral autoregulation-the brain's ability to maintain constant blood flow despite changes in systemic pressure-fails. Blood flow to the penumbra (salvageable brain tissue) becomes directly dependent on Mean Arterial Pressure (MAP). Permissive hypertension is a strategy to maintain this crucial cerebral perfusion pressure (CPP), preventing infarct extension. Lowering BP too aggressively can worsen neurological outcomes by starving the penumbra of oxygen.

• BP Management Algorithm: Treatment hinges on eligibility for IV thrombolysis (alteplase).

• Preferred IV Agents:
  • Labetalol: 10-20 mg IV over 1-2 min, may repeat.
  • Nicardipine: 5 mg/hr IV infusion, titrate up.
  • Clevidipine: 1-2 mg/hr IV infusion, titrate up.
  • ⚠️ Avoid agents causing precipitous drops (e.g., IV hydralazine).

⭐ A sudden drop in blood pressure can convert a salvageable ischemic penumbra into a completed infarct, effectively worsening the stroke's final outcome.

Hemorrhagic Stroke - Aggressive Lowering

• Primary Goal: Prevent hematoma expansion & control intracranial pressure (ICP).
• General Target: For spontaneous ICH with SBP >150 mmHg, acutely lower SBP to <140 mmHg.
  • If initial SBP is >220 mmHg, a more gradual reduction may be considered.
• First-Line IV Agents:
  • Labetalol: Dual α/β blocker.
  • Nicardipine: Titratable calcium channel blocker.
  • Clevidipine: Ultrashort-acting calcium channel blocker.
• Monitoring: Continuous arterial BP monitoring is preferred to avoid hypotension and maintain cerebral perfusion pressure (CPP).

⭐ The ATACH-2 trial showed that intensive BP lowering to a target of 110-139 mmHg did not significantly reduce death or severe disability compared to a standard target of 140-179 mmHg, but it is associated with a small reduction in hematoma growth.

High-Yield Points - ⚡ Biggest Takeaways

• In acute ischemic stroke, practice permissive hypertension (allow BP up to 220/120 mmHg) if no fibrinolytics are given.
• For patients receiving thrombolysis (alteplase), BP must be <185/110 mmHg before infusion and maintained <180/105 mmHg for 24 hours after.
• In intracerebral hemorrhage, aggressively lower systolic BP to a target of <140 mmHg.
• First-line IV agents for BP control in stroke are labetalol and nicardipine.